These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 16432143)

  • 1. Inflammatory, immune, and viral aspects of inclusion-body myositis.
    Dalakas MC
    Neurology; 2006 Jan; 66(2 Suppl 1):S33-8. PubMed ID: 16432143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding the immunopathogenesis of inclusion-body myositis: present and future prospects.
    Dalakas MC
    Rev Neurol (Paris); 2002 Oct; 158(10 Pt 1):948-58. PubMed ID: 12407303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shared blood and muscle CD8+ T-cell expansions in inclusion body myositis.
    Dimitri D; Benveniste O; Dubourg O; Maisonobe T; Eymard B; Amoura Z; Jean L; Tiev K; Piette JC; Klatzmann D; Herson S; Boyer O
    Brain; 2006 Apr; 129(Pt 4):986-95. PubMed ID: 16455793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sporadic inclusion body myositis: a continuing puzzle.
    Needham M; Mastaglia FL
    Neuromuscul Disord; 2008 Jan; 18(1):6-16. PubMed ID: 18160291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulated inducible co-stimulator (ICOS) and ICOS-ligand in inclusion body myositis muscle: significance for CD8+ T cell cytotoxicity.
    Schmidt J; Rakocevic G; Raju R; Dalakas MC
    Brain; 2004 May; 127(Pt 5):1182-90. PubMed ID: 15047591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inclusion body myositis with human immunodeficiency virus infection: four cases with clonal expansion of viral-specific T cells.
    Dalakas MC; Rakocevic G; Shatunov A; Goldfarb L; Raju R; Salajegheh M
    Ann Neurol; 2007 May; 61(5):466-75. PubMed ID: 17366634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory muscle diseases: a critical review on pathogenesis and therapies.
    Dalakas MC
    Curr Opin Pharmacol; 2010 Jun; 10(3):346-52. PubMed ID: 20409756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of muscle biopsy, clinical course, and outcome in PM and sporadic IBM.
    Chahin N; Engel AG
    Neurology; 2008 Feb; 70(6):418-24. PubMed ID: 17881720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCR7+ myeloid dendritic cells together with CCR7+ T cells and CCR7+ macrophages invade CCL19+ nonnecrotic muscle fibers in inclusion body myositis.
    Tateyama M; Fujihara K; Misu T; Itoyama Y
    J Neurol Sci; 2009 Apr; 279(1-2):47-52. PubMed ID: 19171354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular mechanisms in inflammatory myopathies.
    Hohlfeld R; Goebels N; Engel AG
    Baillieres Clin Neurol; 1993 Nov; 2(3):617-35. PubMed ID: 8156145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of inclusion body myositis.
    Cherin P
    Curr Opin Rheumatol; 1999 Nov; 11(6):456-61. PubMed ID: 10551668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on idiopathic inflammatory myopathies.
    Briani C; Doria A; Sarzi-Puttini P; Dalakas MC
    Autoimmunity; 2006 May; 39(3):161-70. PubMed ID: 16769649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory disorders of muscle: progress in polymyositis, dermatomyositis and inclusion body myositis.
    Dalakas MC
    Curr Opin Neurol; 2004 Oct; 17(5):561-7. PubMed ID: 15367860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sporadic inclusion body myositis--diagnosis, pathogenesis and therapeutic strategies.
    Dalakas MC
    Nat Clin Pract Neurol; 2006 Aug; 2(8):437-47. PubMed ID: 16932602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review: An update on inflammatory and autoimmune myopathies.
    Dalakas MC
    Neuropathol Appl Neurobiol; 2011 Apr; 37(3):226-42. PubMed ID: 21155862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonal restriction of T-cell receptor expression by infiltrating lymphocytes in inclusion body myositis persists over time. Studies in repeated muscle biopsies.
    Amemiya K; Granger RP; Dalakas MC
    Brain; 2000 Oct; 123 ( Pt 10)():2030-9. PubMed ID: 11004120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Light and electron microscopic immunolocalization of presenilin 1 in abnormal muscle fibers of patients with sporadic inclusion-body myositis and autosomal-recessive inclusion-body myopathy.
    Askanas V; Engel WK; Yang CC; Alvarez RB; Lee VM; Wisniewski T
    Am J Pathol; 1998 Apr; 152(4):889-95. PubMed ID: 9546349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sporadic inclusion body myositis: counts of different types of abnormal fibers.
    Pruitt JN; Showalter CJ; Engel AG
    Ann Neurol; 1996 Jan; 39(1):139-43. PubMed ID: 8572661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-amyloid is a substrate of autophagy in sporadic inclusion body myositis.
    Lünemann JD; Schmidt J; Schmid D; Barthel K; Wrede A; Dalakas MC; Münz C
    Ann Neurol; 2007 May; 61(5):476-83. PubMed ID: 17469125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association of sporadic inclusion body myositis and Sjögren's syndrome in carriers of HLA-DR3 and the 8.1 MHC ancestral haplotype.
    Rojana-udomsart A; Needham M; Luo YB; Fabian V; Walters S; Zilko PJ; Mastaglia FL
    Clin Neurol Neurosurg; 2011 Sep; 113(7):559-63. PubMed ID: 21507567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.